ACELYRIN Inc SLRN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 10:59 AM EDT
4.47quote price arrow down-0.16 (-3.46%)
Volume
84,450
52 week range
4.14 - 29.88
Loading...
  • Open4.67
  • Day High4.68
  • Day Low4.46
  • Prev Close4.63
  • 52 Week High29.88
  • 52 Week High Date08/23/23
  • 52 Week Low4.14
  • 52 Week Low Date04/30/24

Key Stats

  • Market Cap442.141M
  • Shares Out98.91M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-39.28

KEY STATS

  • Open4.67
  • Day High4.68
  • Day Low4.46
  • Prev Close4.63
  • 52 Week High29.88
  • 52 Week High Date08/23/23
  • 52 Week Low4.14
  • 52 Week Low Date04/30/24
  • Market Cap442.141M
  • Shares Out98.91M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-39.28

RATIOS/PROFITABILITY

  • EPS (TTM)-2.59
  • P/E (TTM)-1.73
  • Fwd P/E (NTM)-1.10
  • EBITDA (TTM)-324.835M
  • ROE (TTM)-95.93%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ACELYRIN Inc

 

Profile

MORE
ACELYRIN, INC. is a late-stage clinical biopharma company. The Company is focused on providing treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The Company has two programs in late-stage clinical development. The Company’s lead product candidate, izokibep, is being evaluated in multiple immunologic indications, including hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and uveitis. The...
Bruce Cozadd
Independent Chairman of the Board
Mina Kim J.D.
Chief Executive Officer, Director
Melanie Gloria
Chief Operating Officer
Gilbert Labrucherie J.D.
Interim Chief Financial Officer, Chief Business Officer
Address
4149 Liberty Canyon Road
Agoura Hills, CA
91301
United States

Top Peers

SYMBOLLASTCHG%CHG
CRBP
Corbus Pharmaceuticals Holdings Inc
44.89-1.03-2.24%
LRMR
Larimar Therapeutics Inc
7.43UNCHUNCH
ALLO
Allogene Therapeutics Inc
2.94-0.07-2.49%
PEPG
PepGen Inc
13.59-0.06-0.44%
KRRO
Korro Bio Inc
51.42+0.16+0.30%